Aluminum / Zinc Phosphide Poisoning (Grain Fumigant — "Rice Tablet")

Overview

Aluminum phosphide (AlP) and zinc phosphide are solid fumigants used to protect grains from pest; AlP is usually in 3 g tablets containing about 56% AlP ('rice/wheat tablet', 'cereal medicine'), and each tablet releases about 1 g of phosphine (PH3) gas with moisture/stomach acid. Phosphine inhibits mitochondrial cytochrome c oxidase (complex IV), stopping cellular respiration, as well as oxidative damage by reactive oxygen species; As a result, energy crisis, resistant myocardial depression, vasoplasia and lactic acidosis develop.

It is a highly lethal poisoning with a high lethality and is mainly suicidal in Turkey and South Asia; In adults, 150-500 mg of lethal is considered and survival is unlikely at an intake of >1.5 g (approximately a single tablet). Zinc phosphide is less potent and the lowest reported lethal dose is about 4 g in man.

The clinic early begins with nausea-vomiting-abdominal pain and garlic/bruise-fishy breath; progresses to resistant hypotension, cardiogenic shock, deep metabolic acidosis, ventricular arrhythmia, ARDS, and liver/kidney injury within hours. The diagnosis largely relies on clinical suspicion and history; in the bedside simple verification method, the silver nitrate test, silver nitrate paper in contact with gastric fluid reacts with phosphine and turns black, and this test shows about 100% positivity in case series published in gastric fluid, whereas the positivity rate drops to about 50% in samples taken from the breath, therefore a negative breath test does not rule out the diagnosis.

In more advanced centers, phosphine can be measured at concentrations as low as 0.2 micrograms/mL using headspace gas chromatography-mass spectrometry, but this method is not available in routine emergency practice. Cardiac involvement is common and prognostically determinative: on electrocardiography, nonspecific ST-T changes, alongside coved-type ST elevation in V1-V3 and right bundle branch block, have been reported as a Brugada phenocopy, and this appearance is often mistaken for acute coronary syndrome; troponin elevation here reflects direct toxic myocardial damage rather than ischemia.

On echocardiography, decreased left ventricular ejection fraction, diffuse hypokinesia, and pericardial effusion may be observed; myocardial dysfunction is generally reversible, and in surviving cases, cardiac lesions have been reported to be completely resolved within six months. In an observational study, NT-proBNP levels of 72 pg/mL and above were reported to predict mortality better than troponin (TO BE CONFIRMED, single-center data).

Overall mortality rates in series range from approximately 30% to 80%, and this wide range depends on the dose taken, delay in presentation, and the capacity of the center for supportive care. For rapid bedside risk stratification, the validated PGI score is based on three simple parameters: pH less than 7.25, Glasgow Coma Scale less than 13, and systolic blood pressure less than 87 mmHg; if all three criteria are present (score 3), specificity for death is approximately 98.2% and the positive predictive value approximately 96.4%, and the score has shown at least equivalent performance compared to the Poisoning Severity Score (PSS) and SAPS II in predicting the need for mechanical ventilation and vasopressors.

THERE IS NO SPECIFIC ANTIDOTE; management involves early, aggressive supportive care and intensive care. Staff safety is critical: phosphine gas is released from vomit and gastric lavage fluid in closed spaces and can poison healthcare workers — ventilation and personal protective equipment are mandatory.

Key considerations

• Methanol or ethylene glycol poisoning presents with high anion gap metabolic acidosis and increased osmolar gap; unlike phosphide, there is usually no garlic-smelling breath or history of agricultural fumigant exposure.
• Salicylate poisoning causes metabolic acidosis (mixed acid-base disorder) along with early respiratory alkalosis, and tinnitus and hyperventilation are prominent; the characteristic cardiogenic shock picture of phosphide is not typical.
• Metformin-associated lactic acidosis usually develops on the basis of renal failure or hypoperfusion, and there is no history of fumigant exposure.
• Diabetic ketoacidosis is recognized with hyperglycemia and ketonemia and can be easily distinguished from phosphide by blood glucose measurement.
• Uremic acidosis occurs with a history of chronic kidney failure and elevated urea-creatinine, and does not include a history of acute fumigant ingestion.
• Organophosphate or carbamate poisoning manifests with cholinergic toxidrome (miosis, bronchorrhea, excessive secretion, fasciculation); cholinergic findings are not expected in phosphide poisoning.
• Cyanide or carbon monoxide poisoning also causes lactic acidosis by disrupting mitochondrial respiration, but a history of burn/smoke inhalation or elevated carboxyhemoglobin is distinguishing.
• Beta-blocker or calcium channel blocker poisoning causes significant bradycardia along with refractory shock; in phosphide poisoning, heart rate is usually preserved or tachycardic.
• Acute coronary syndrome may be mistakenly considered due to Brugada phenocopy or coved ST elevation seen in phosphide poisoning; however, a history of toxic fumigant exposure and accompanying severe metabolic acidosis do not support a true coronary event.
• Septic or cardiogenic shock from other causes is supported by a history of an infection focus or structural heart disease and there is no history of fumigant exposure.
• Occupational exposure to phosphine gas through direct inhalation (during silo, warehouse, or container ventilation) can produce the same toxidrome via the respiratory route alone without tablet ingestion; a history of working in an enclosed storage environment instead of tablet ingestion is distinguishing.

Why it matters

Since phosphine is a reversible mitochondrial poison and there is no specific antidote, the basis of treatment is aggressive supportive therapy that keeps the patient alive until cellular recovery occurs. The main causes of death are refractory cardiogenic shock and severe metabolic acidosis; therefore, early intensive care, invasive hemodynamic monitoring, careful titration of fluids (avoiding overload due to the cardiogenic component), vasopressors like norepinephrine, and inotropes like dobutamine in myocardial depression are prioritized; myocardial dysfunction is often reversible, so VA-ECMO/IABP can serve as a bridge in selected centers.

Correction of acidosis with sodium bicarbonate has been associated with better survival in observational data, but there is no randomized evidence. The chemical basis of the traditionally used potassium permanganate (KMnO4) lavage for GI decontamination has been seriously questioned in recent years; it has been suggested that, due to phosphine being a 'hard' nucleophile, the interaction with free oxygen radicals released from the decomposition of KMnO4 does not occur as expected, and it has been argued that this practice does not have an evidence-based foundation (TO BE VERIFIED, controversial view — old teaching is being questioned).

In contrast, in a study examining decontamination with liquid oil/paraffin, the use of paraffin oil was reported to reduce mortality by about 41%, the need for intubation by about 41%, and vasopressor requirement by about 29% (TO BE VERIFIED, single study data); lavage with water is avoided because it increases phosphine release, and the benefit of activated charcoal is controversial due to the molecular weight and absorption properties of phosphide. Magnesium sulfate, N-acetylcysteine, high-dose insulin/GIK, and intralipid have been tried as adjuvants.

In a small randomized controlled trial of thirty-six patients, adding vitamin E to standard treatment significantly reduced mortality (15% vs 50%, p=0.02) and the need for mechanical ventilation (30% vs 62%, p<0.05); however, this is a single RCT with a small sample size and awaits verification (TO BE VERIFIED). There is also a guideline-level controversy regarding NAC: while the meta-analysis of 4 RCTs/177 diseases mentioned above gives a signal of mortality benefit (RR 0.5), in another randomized controlled study of 96 patients, there was no significant difference between adding NAC infusion to standard treatment and standard treatment alone in terms of mortality (p=0.601) and the need for mechanical ventilation (p=0.505); therefore, the routine use of NAC remains controversial, and a definitive recommendation cannot be made based on a single study.

None of them are a true antidote; early, high-quality resuscitation and organ support are determinant rather than exaggerated expectations.

Critical complications

• Refractory cardiogenic shock and toxic myocarditis can develop; troponin rises and ejection fraction decreases on echocardiography. The treatment is vasopressor-inotropic support and intensive care monitoring, and in most cases, myocardial function fully recovers within six months.
• Ventricular arrhythmia and Brugada phenocopy may be observed; since coved ST elevation in V1-V3 can be confused with acute myocardial infarction, the ECG should be interpreted in the context of toxic etiology and standard arrhythmia management should be applied.
• Acute respiratory distress syndrome (ARDS) may develop; it is recognized by Berlin criteria and managed with lung-protective mechanical ventilation strategy.
• Acute kidney injury may develop; if refractory metabolic acidosis or hemodynamic instability accompanies, continuous renal replacement therapy or hemodialysis should be considered early.
• Liver injury can manifest as transaminase elevation and jaundice; since this damage may appear delayed over days to weeks, liver function tests should be monitored even after discharge.
• After gastrointestinal decontamination performed with fluid fat or potassium permanganate, corrosive damage, stricture, or rarely fistula may develop in the esophagus and gastric mucosa; in a patient with dysphagia, endoscopic evaluation is necessary.
• Excessive sodium bicarbonate administration can lead to iatrogenic metabolic alkalosis, hypernatremia, and hypokalemia; therefore, bicarbonate should be titrated with serial blood gases and overcorrection should be avoided.
• Phosphine gas released from vomit or lavage fluid in a closed environment can cause headache, nausea, and rarely serious secondary poisoning in healthcare workers; therefore, ventilation and personal protective equipment are mandatory for the safety of the treatment team.
• Gastric lavage with potassium permanganate may lead to hemolysis and methemoglobinemia; since this agent is also a strong oxidant and hemolytic substance, hemogram and methemoglobin levels should be monitored if it is used.

Special considerations

• During pregnancy, case reports have indicated that aggressive supportive treatment with a combination of N-acetylcysteine and coenzyme Q10 was completed with positive outcomes for both mother and fetus without the need for extracorporeal life support; however, this data is based on a small number of case reports, and management decisions should always be made together with the obstetrics team under fetal monitoring.
• In pediatric patients, pathophysiology is the same as in adults and treatment principles do not change, but dosing is calculated according to body weight, and it should be kept in mind that smaller absolute intake amounts can disproportionately lead to severe clinical presentations.
• In patients with renal failure or those who develop acute kidney injury during treatment, continuous renal replacement therapy or hemodialysis should be initiated early in cases of refractory metabolic acidosis; although the evidence for phosphine clearance by dialysis is limited, it is beneficial for supporting acid-base and fluid balance.
• In patients with liver failure, hepatotoxicity can progress with delayed onset over weeks to months, so the duration of monitoring liver function tests should be extended compared to standard poisonings.
• In geriatric patients, tolerance to cardiogenic shock is lower due to cardiovascular comorbidity and reduced physiological reserve; in this group, the threshold for invasive hemodynamic monitoring should be further lowered.
• In diabetic patients, if high-dose insulin/glucose-insulin-potassium therapy is to be applied, it should be remembered that glycemic control may become more complex and blood glucose/potassium levels need to be measured more frequently.

Follow-up plan

Closely monitor serial ECG, blood gases, lactate, electrolytes, magnesium, glucose, liver and kidney functions; assess left ventricular function with echocardiography and, if possible, follow NT-proBNP levels, as observational data has reported that this marker predicts mortality better than troponin (TO BE CONFIRMED). In refractory shock/acidosis, contact the relevant units early for VA-ECMO and renal replacement.

Cardiac lesions are generally reversible and complete recovery has been reported within six months in surviving cases; therefore, repeat echocardiography should be planned during post-discharge cardiology follow-up. If decontamination has been performed with oil or KMnO4, warn the patient for the development of dysphagia or odynophagia and, if necessary, refer for endoscopic evaluation; esophageal stricture may appear weeks later.

Call the National Poison Consultation Center of the Ministry of Health of Turkey (UZEM 114) for the agent, dose, and current management. In the context of suicide attempt, conduct a psychiatry consultation and safety assessment; ventilate the environment for staff phosphine exposure and use protective equipment.